Home » Posts tagged 'ana'

Tag Archives: ana

Alan Green covers Petroteq #PQE and Ananda Developments #ANA on this week’s Stockbox Research Talks

Alan Green covers Petroteq #PQE and Ananda Developments #ANA on this week’s Stockbox Research Talks.

Ananda Developments #ANA – Exercise of Warrants

 

ana

Ananda announces that 16,863 ordinary shares of 0.2p each in the Company (“Ordinary Shares”) have been issued following the exercise of warrants at 0.45p per share.

Application will be made for the new Ordinary Shares to be admitted to trading on the Access segment of the AQSE Growth Market and admission is expected to become effective on Tuesday, 11 January 2022.

Following this issue, the Company has 797,579,590 Ordinary Shares in issue, each share carrying the right to one vote.

This figure of 797,579,590 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA’s Disclosure and Transparency Rules.

Ananda Developments #ANA – Interim Results to 31 July 2021

 

ana

Unaudited Interim Results for the six months ended 31 July 2021

The Directors present the interim results of Ananda Developments Plc for the period from 1 February 2021 to 31 July 2021.

These interim results have not been audited nor have they been reviewed by the Company’s auditors under ISRE 2410 of the Auditing Practices Board.

UPDATE ON INVESTMENTS AND ACTIVITIES

Ananda’s ambition is to be a UK-based grower of carbon neutral, consistent, high quality medical cannabis for domestic and international markets.

ICAN Israel Cannabis Limited (“iCAN”)

In the period under review, iCAN has expanded its conference platform and increased the number of companies in its incubator group.  Since the end of the reporting period, iCAN has transitioned to an online offering to maintain revenue streams during the COVID-19 pandemic.  The Company has converted its convertible debt into additional equity in iCAN.

Liberty Herbal Technologies Limited (“LHT”)

LHT launched hapac®, a dry herb medicinal cannabis inhaling technology, in Italy in late 2018.  LHT was founded by ex-British American Tobacco executives from the e-cigarette innovation and sales divisions, who bring with them a deep understanding of strict regulatory environments and the procedures and protocols required to develop and commercialise technologies of this nature.  Sales increased from launch however due to COVID they stagnated and fell during mid 2020.  The Italian operations remain open, ready for relaunch when COVID allows, and the company continues to refine the dry herb vaping device and explore opportunities to grow the business in the North American, European and UK markets.

Tiamat Agriculture Limited (“TAL”) and DJT Group Limited (“DJT”)

TAL is a wholly owned subsidiary of the Company and DJT is owned 50% by TAL and 50% by TAL’s joint venture partners Anglia Salads Limited and JEPCO Marketing Limited (together, “JEPCO”). DJTG is the 100% owner of DJT Plants Limited (“Plants”)

In October 2019, Plants submitted its application to the Home Office Drugs and Firearms Licencing Unity (“DFLU”) to grow >0.2% THC cannabis in Lincolnshire. Throughout the year Plants and its advisors continued to correspond with DFLU officials in order to progress the licence application through the various phases to the current position of awaiting a site visit from the DFLU.  The Home Office made a physical site visit on 17 March 2021 and the Licence was received on 17 May 2021.

On 15 February 2021, Ananda announced that it had raised £300,000 for the build out of its research facility at the Licence location. As reported to shareholders at the time, these funds were set aside for the build out. DJT Plants will therefore immediately commence the build out and commissioning of the research facility.

On 8 June 2021, Ananda announced that it had entered into a non-binding Heads of Terms for the proposed acquisition by Ananda of the 50% shareholding in DJT currently owned by JEPCO. This transaction is ongoing.

On 14 July 2021, Ananda announced that it had raised £550,000 by way of the issue of 1p convertible loan notes (“CLNs”) with a fixed life of 2 years and an interest rate of 12.5%. The interest accrued on these notes will be rolled up and satisfied by the issue of ordinary shares at the end of the 2-year terms. The proceeds from the issue of the CLNs will be used to fund the ongoing build of Plants’ cannabis cultivation and research facility.

On behalf of the board

Melissa Sturgess, Chief Executive Officer

21 October 2021

6 months to 31 July 2021

Unaudited

Year ended 31 January 2021
Audited
6 months to 31 July 2020

Unaudited

Note £ £ £
Administrative expenses (688,498) (496,110) (151,089)
Interest received 114 114
Loss from operations (668,498) (495,996) (150,975)
Taxation
Foreign Exchange Translation Gain / (Loss) 1 (149) (887) 1,157
Total loss for the period (688,647) (495,109) (149,818)

 

Earnings per share
Basic and diluted earnings per share (pence) 2 (0.10p) (0.11p) (0.07p)

There was no other comprehensive income in the period.

6 months to 31 July 2020

Unaudited

Year ended 31 January 2021
Audited
6 months to 31 July 2020

Unaudited

£ £ £
Fixed assets
Investments 1,313,811 1,280,618 1,401,250
1,313,811 1,280,618 1,401,250
Current assets
Debtors 50,000 12,718 28,672
Cash at bank and in hand 3,638
Total current assets 50,000 12,718 32,310
Creditors: amounts falling due within one year 863,564 462,299 308,898
Net current assets (813,564) (449,581) (276,588)
Total assets less current liabilities 500,247 831,037 1,124,662
Capital and reserves
Share capital 1,589,004 928,278 882,194
Share premium 766,336 689,229 689,229
Share option reserve 67,361 447,337 441,755
Retained earnings (1,922,454) (1,233,807) (888,516)
Total equity and liabilities 500,247 831,037 1,124,662

The interim financial statements were approved and authorised for issue by the Board and were signed on its behalf by:

Melissa Sturgess

Chief Executive Officer

[

21 October 2021

Share Capital Share Premium Share Option Reserve Retained Earnings Total
£ £ £ £ £
As at 1 February 2021 928,278 689,229 447,337 (1,233,807) 831,037
Total comprehensive loss for the period (688,647) (688,647)
Proceeds from share issue 660,726 77,107 737,833
Issue of share options (379,976) (379,976)
Balance at 31 July 2021 1,589,004 766,336 67,361 (1,922,454) 500,247

 

Share Capital Share Premium Share Option Reserve Retained Earnings Total
£ £ £ £ £
As at 1 February 2020 836,111 689,229 441,755 (738,698) 1,228,397
Total comprehensive loss for the year (495,109) (495,109)
Proceeds from share issue 92,167 92,167
Issue of share options 5,582 5,582
Balance at 31 January 2021 928,278 689,229 447,337 (1,233,807) 831,037

 

Share Capital Share Premium Share Option Reserve Retained Earnings Total
£ £ £ £ £
As at 1 February 2020 836,111 689,229 441,755 (738,698) 1,228,397
Total comprehensive loss for the period (149,818) (149,818)
Proceeds from share issue 46,083 46,083
Balance at 31 July 2021 882,194 689,229 441,755 (888,516) 1,124,662

The following describes the nature and purpose of each reserve within owners’ equity:

Reserve Description and purpose
Share capital This represents the nominal value of shares issued.
Share premium Amount subscribed for share capital in excess of nominal value.
Retained earnings Cumulative net gains and losses recognised in the statement of comprehensive income.

ACCOUNTING POLICIES

General information

Ananda Developments Plc’s interim financial statements are presented in British Pound Sterling (GBP) which is the functional currency of the parent company.  These interim financial statements were approved for issue by the Board of Directors on 21 October 2021.

The financial information set out in these interim financial statements does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006.  The Company’s statutory financial statements for the year ended 31 January 2021 have been filed with the Registrar of Companies.  The auditor’s report on those financial statements was unqualified and did not contain a statement under Section 498(2) of the Companies Act 2006.

These interim results have not been audited nor have they been reviewed by the Company’s auditors under ISRE 2410 of the Auditing Practices Board.

Basis of preparation

These interim financial statements are for the six month period ended 31 July 2021.  They have been prepared following the recognition and measurement principles of FRS 102.  They do not include all of the information required for full annual financial statements and should be read in conjunction with the financial statements for the period ended 31 January 2021.

These interim financial statements have been prepared on a going concern basis which the Directors believe to be appropriate.

These interim financial statements have been prepared in accordance with the accounting policies adopted in the financial statements for the period ended 31 January 2021.

1.  Foreign currency transactions

Transactions in foreign currencies are translated to GBP at the exchange rates at the dates of the transactions.  Monetary assets and liabilities denominated in foreign currencies at the reporting date are translated to GBP at the exchange rate on that date.  Foreign exchange differences arising on translation are recognised in the statement of comprehensive income.

2.  Earnings per share

The calculation of earnings per share is based on the loss attributable to ordinary shareholders divided by the average number of shares in issue during the period.

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess
+44 (0)7717 573 235
ir@anandadevelopments.com
Investor Relations
Jeremy Sturgess-Smith
PETERHOUSE CAPITAL LIMTED
Corporate Finance
Mark Anwyl
Guy Miller
+44 (0)20 7469 0930
Corporate Broking
Lucy Williams
Duncan Vasey
CELICOURT COMMUNICATIONS
Mark Antelme
Ollie Mills
+44 (0)20 7520 9266

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Alan Green discusses Petroteq $PQE $PQEFF & Ananda Developments #ANA on the Stockbox Research podcast

Alan Green discusses Petroteq $PQE $PQEFF & Ananda Developments #ANA on the Stockbox Research podcast.

Alan Green talks Open Orphan #ORPH, Aquis #AQX & Ananda Developments #ANA

Alan Green talks Open Orphan #ORPH, Aquis #AQX & Ananda Developments #ANA

Ananda Developments #ANA – DJT Plants’ Cannabis Flower approved for Israel Import

ananda developments logoAnanda, which is creating UK-based operations to grow and provide carbon neutral, consistent, high quality medical cannabis for the UK and international markets, announces that the Government of Israel has granted a licence for cannabis flower grown at Ananda’s subsidiary, DJT Plants Limited (“DJT Plants”) to be imported into Israel.  The licence is held by Cannasoul Analytics, the research company which will be analysing DJT Plants’ cannabis flower.

The purpose of obtaining an import licence at this early stage is to ensure that DJT Plants has a clear understanding of all requirements for moving cannabis flower, a controlled drug under the UK Government’s Misuse of Drugs Act 1971, from the UK into Israel. The import licence was awarded by Israel’s Department of Pharmaceutical Import and Narcotics at the Ministry of Health, and by the Ministry of Agriculture and Rural Development Plant Protection and Inspection Services.  Appropriate licences will be sought under the relevant UK legislation allowing the export of cannabis flower from the UK nearer to the time of export.

In April 2020, Ananda announced that it would be collaborating with Professor Dedi Meiri, the leading global medical cannabis researcher at The Technion in Israel, to carry out detailed molecular analysis of the strains of cannabis which Ananda proposes to grow and stabilise at DJT Plants.

As part of Ananda’s research plan to stabilise 65 strains of medical cannabis and conduct field trials, future cannabis plant material grown by DJT Plants will be sent to Cannasoul Analytics, an Israel-based commercial research company formed by Professor Dedi Meiri, for analysis of cannabinoid, terpene and flavonoid profiles.  It is the view of the Directors of Ananda that Israel continues to be at the forefront of global medical cannabis research and that Israel’s experts have the greatest depth of understanding of the cannabis plant at the molecular level.

Ananda’s ultimate ambition is for DJT Plants to transition to commercial growing of medical cannabis.  The Board remains encouraged by progress.

Preparation of documentation continues for the acquisition of the 50% of DJT Group Limited not already owned by Ananda. This work includes the drafting of a range of supporting agreements. Further detail on the proposed acquisition is detailed in the Company’s announcement of 8 June, 2021.

Ananda’s CEO, Melissa Sturgess, commented: “We don’t underestimate the complexity of the work required to grow medical cannabis in the UK.  The prize, however, is big; both from a patient care and a financial perspective.  Delivering the best quality, consistent medical cannabis medicine to UK and international patients is our clear objective.  We continue to work in a focused and diligent manner towards achieving our goals.”

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess

Investor Relations
Jeremy Sturgess-Smith

+44 (0)7463 686 497
ir@anandadevelopments.com
PETERHOUSE CAPITAL LIMITED
Corporate Finance
Mark Anwyl

Corporate Broking
Lucy Williams
Duncan Vasey

YELLOW JERSEY PR
Alison Hicks
Charles Goodwin

+44 (0)20 7469 0930

+44 (0) 7585 953 660
+44 (0) 7747 788 221

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Ananda Developments #ANA – Exercise of Warrants

Ananda announces that 163,369 ordinary shares of 0.2p each in the Company (“Ordinary Shares”) have been issued following the exercise of warrants at 0.45p per share. The proceeds received by the Company will be used for general working capital purposes.

Application will be made for the new Ordinary Shares to be admitted to trading on the Access segment of the AQSE Growth Market and admission is expected to become effective on Tuesday, 31 August 2021.

Following this issue, the Company has 794,665,248 Ordinary Shares in issue, each share carrying the right to one vote.

This figure of 794,665,248 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA’s Disclosure and Transparency Rules.

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess

Investor Relations
Jeremy Sturgess-Smith

+44 (0)7717 573 235
ir@anandadevelopments.com
PETERHOUSE CAPITAL LIMITED
Corporate Finance
Mark Anwyl

Corporate Broking
Lucy Williams
Duncan Vasey

+44 (0)20 7469 0930

Market Abuse Regulation (MAR) Disclosure

Ananda Developments #ANA – Board Change

Ananda announces that Peter Redmond has stepped down as a non-executive Director of the Company with effect from 23 August 2021. Mr Redmond was appointed to the Board of Ananda in June 2019, to represent the interests of URA Holdings plc (“URA”) following URA’s investment in the Company.  Following the May 2021 distribution of URA’s interests in Ananda to its shareholders, Mr Redmond has decided to leave the Company to pursue his other business interests.

The Directors of Ananda thank Mr Redmond for his contribution to the Company.

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess

Investor Relations
Jeremy Sturgess-Smith

+44 (0)7717 573 235
ir@anandadevelopments.com
PETERHOUSE CAPITAL LIMITED
Corporate Finance
Mark Anwyl

Corporate Broking
Lucy Williams
Duncan Vasey

+44 (0)20 7469 0930

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Andrew Hore – Quoted Micro 16 August 2021

AQUIS STOCK EXCHANGE

Yooma Wellness Inc (YOOM) has a dual quotation on the Canadian Securities Exchange and obtaining the Aquis quotation is part of the stated strategy to become the largest CBD business in the world. Acquisitions have been made this year and at least three more are lined up. Prior to joining Aquis, Yooma raised £7.46m at 52.32p a share. As well as the cash raised in the placing, there is an option granted to a strategic investor to subscribe £5m for 9.56 million shares. Administrative delays relating to the investor mean that the share issue has not been completed yet. Yooma Wellness says that annualised 2021 sales could be $32m if it makes the expected acquisitions.

Ecotricity has posted its offer document for Good Energy (GOOD), which continues to reject the approach.

Clean Invest Africa (CIA) is in discussions with a potential investor. A fundraising could be secured within weeks. There are also discussions concerning a joint venture. CIA has been hit by Covid-19 measures in South Africa.

Pioneer Media Holdings Inc (PNER) has made an additional investment in connected gaming platform developer Paidia eSports Inc and a new £200,000 investment in Streaks Gaming. Pioneer will own 40% of Paidia. London-based Streaks operates a conversational gaming platform. Users are matched with a personalised digital conversational partner generated by AI. Pioneer will own 16.1% of Streaks.

Sativa Wellness Group Inc (SWEL) increased revenues by 828% in the second quarter of 2021. Revenues in the six months to June 2021, revenues jumped from £733,000 to £4.86m, while the loss reduced from £2.37m to £1.27m. The business is being restructured into three divisions: Goodbody Botanicals, Phytovista and Goodbody Wellness.

Construction of the DJT Plants medical cannabis growing facility started on 4 July. Ananda Investments (ANA) continues to make progress with the purchase of the 50% of DJT it does not own.

Rutherford Health (RUTH) is partnering with genomic and theranostic company OncoDNA, which will enable its patients to obtain genomic testing that can help to secure the most appropriate cancer treatment.

Administrators have been appointed to NQ Minerals (NQMI).

Chris Akers has increased his stake in Oscillate (MUSH) from 3.1% to 9%. Thomas Grant Nominees owns 9.95%. Robert Johnson has a 3% stake in TECC Capital (TEC).

AIM

Drug developer BiVictriX Therapeutics (BVX) has a low capital cost model which outsources the main operations. It has a lead asset called BVX001, which is targeting adult leukaemia. BVX001 has already indicated an anti-tumour effect in animal models. No adverse effects were observed. The £7.5m raised at 20p a share will accelerate the optimisation of BVX001, so it reaches pre-clinical milestones. The share price ended the week at 23.5p.

Marlowe (MRL) has decided not to bid for Restore (RST), which has acquired PRM Green Technologies, which is an IT recycling business. This acquisition will be immediately earnings enhancing.

Crestchic revenues increased by 44% in the first half of 2021 and Northbridge Industrial Services (NBI) group revenues are 22% ahead at £19.6m. The 2021 pre-tax profit forecast was increased from £2.1m to £2.5m.

Self-storage sites operator Lok’nStore (LOK) is increasing occupancy rates and adding new sites. Self-storage revenues increased by 21% over the year to July 2021, which is well ahead of forecasts. The first half growth rate was 11%. Over the 12-month period, occupancy rates have increased from 69.6% to 85.8%.

Oil and gas producer Southern Energy Corp (SOUC) concentrates on areas with proven low-cost producing assets, with the current focus in Mississippi. The strategy is to grow production through acquisitions. Alberta-based Southern Energy plans to increase production to 25,000 barrels of oil per day over the next two year. This will require larger acquisitions than in the past. No cash was raised, and the shares will continue to be traded on the TSX Venture Exchange. The share price opened at 6.5p on the first day and stayed at that level until the end of the second day when it fell to 5p (4p/6p) and that price was maintained.

Science Group (SAG) has made a bid approach for TP Group (TPG). Science group has acquired a 10.2% stake in TPG, with the shares being acquired for 5p each.

Best of the Best (BOTB) says that there has been a 15% decline average weekly sales of competition entries. finnCap has cut its earnings forecast from 142.4p a share to 53.3p a share. There should still be £12m in cash at the end of April 2022.

Venture Life Group (VLG) says interim revenues were lower this year because of the lack of hand sanitiser sales and lower sales of Dentyl in China. Sales of other products grew. Forecasts have been updated for recent acquisitions. Share issues mean that earnings are expected to be flat at 2.5p a share. The full benefits of the acquisitions will come through in 2022 when earnings are expected to be 4.6p a share.

Verditek (VDTK) has raised £353,000 from its Crowd for Angels bond offering.

MAIN MARKET

Foams manufacturer Zotefoams (ZTF) improved its interim pre-tax profit by 49% to £4m even though it was reduced by currency movements. Footwear generates one-third of revenues. The new manufacturing site in Poland has opened.

Argo Blockchain (ARB) generated revenues of £31.1m from mining 883 bitcoin in the first half of 2021. Although revenues are improving, there will be higher than expected tax and finance charges this year. finnCap has reduced its 2021 earnings estimate from 7.6p a share to 5.6p a share.

Plaza Centers NV (PLAZ) has received a revised proposal from GC Hevron Capital. The company’s assets would be transferred to a trustee of managed for the benefit of bondholders. Hevron would be issued shares equivalent to 74.99% of the enlarged share capital. There will be a NIS 2 million payment to cover creditors. Hevron will then inject a new business, which is part of its investment portfolio, into the shell. The target is a nutritional food technology company.

Danakali (DNK) is cancelling its standard listing on 24 September and retaining its ASX listing.

Mast Energy Developments (MAST) has acquired Pyebridge Power, which owns a 9MW gas-powered standby generation facility, for £2.5m in cash. The site could generate EBITDA of £488,000 a year.

Hawkwing (HNG) is raising £16.5m through the issue of 8% convertible loan notes. They are convertible at 6p a share. The cash will be loaned to ecommerce aggregator Internet Fusion Group to finance two acquisitions – an outdoor lifestyle brand and an online fashion accessories retailer. Hawkwing plans to acquire Internet Fusion for an enterprise value of £115m through an issue of shares at 6p each. Trading in Hawkwing shares remains suspended.

Path Investments (PATH) has agreed to acquire DG Innovate for £32m in shares at 0.6p each. DG is developing electric motor technologies and energy storage systems. There is enhanced drive technology, which is being used to develop lightweight and cost-effective electric motors, and enhanced battery technology, which is developing fully-recyclable, sodium-ion batteries offering greater energy density than current technologies.

Andrew Hore

Ananda Developments #ANA – Update on Medical Cannabis Research Growing Facility

Ananda’s ambition is to be a UK-based grower of carbon neutral, consistent, high quality medical cannabis for domestic and international markets.  In 2025, the UK medical cannabis market is expected to be worth £450m and the European market is expected to be worth £2.7bn.

HIGHLIGHTS

  • Construction works at DJT Plants Limited’s (“DJT Plants”) medical cannabis research growing facility commenced on 4 July 2021
  • Dr Hadar Less, DJT Plants’ Chief Grower, has met the UK based construction team on site
  • Preparation of documents continues for the acquisition of the 50% of DJT Group Limited (“DJT Group”) not already owned by Ananda

MEDICAL CANNABIS RESEARCH GROWING FACILITY

Since the last update on 25th June 2021, works have commenced on schedule at the UK based research growing facility site. There has been a post-COVID construction boom and although materials costs have risen since the project was originally scoped it is fully funded from Ananda’s current cash reserves.  Once construction is complete, DJT Plants will commence planting its first medical cannabis for its research programme.  DJT’s ultimate ambition is to transition to commercial growing of medical cannabis.  The Board is highly encouraged by progress to date.

Dr Hadar Less, DJT Plants’ Chief Grower, has spent time on site, met with the construction team and scoped out the job description for the Facility Manager who will be recruited to report directly to him.

Dr Less’ expertise is in plant genetics.  He was the Agriculture Division Manager at BOL Pharma, CEO of BOL Agrotech and has experience managing large teams.  BOL is one of the largest medical cannabis cultivation and production companies in Israel.  Israel has a more mature medical cannabis sector than the UK and has, arguably, a medical cannabis prescribing framework that is most like that in the UK in that patients have to have exhausted other forms of medication to be prescribed cannabis.  Dr Less was actively involved in the development of DJT Plants’ successful licence application to the Home Office of the UK Government and his experience is directly applicable to DJT’s immediate research initiatives and ultimate commercial growing ambitions.

Ananda’s CEO Melissa Sturgess commented; “Our team grew medical cannabis under contract for GW Pharmaceuticals, providing a great foundation for our ambitions.  The first part of our research plan is to stabilise 65 strains of medical cannabis to add to the body of knowledge about growing in UK conditions.  We want to create a scientific and operational platform from which we can move to commercial growing.”

Further updates will be provided as plans progress.

ACQUISITION OF 50% OF DJT GROUP NOT ALREADY OWNED BY ANANDA

A circular containing further information and convening a General Meeting to approve, amongst other things, the acquisition by Ananda of the 50% shareholding in DJT Group not currently owned by Ananda, will be sent to Ananda shareholders as soon as possible.  A further announcement will be made at that time.

-Ends-

The Directors of the Company accept responsibility for the contents of this announcement.

ANANDA DEVELOPMENTS PLC
Chief Executive Officer
Melissa Sturgess

Investor Relations
Jeremy Sturgess-Smith

+44 (0)7463 686 497
ir@anandadevelopments.com
PETERHOUSE CAPITAL LIMITED
Corporate Finance
Mark Anwyl

Corporate Broking
Lucy Williams
Duncan Vasey

+44 (0)20 7469 0930

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed by the Company to constitute inside information. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.